Halozyme Therapeutics, Inc.

Median copy kept +71.5% from the filing vs +59.6% from the trade date; the lag took -12.0 pts. The S&P returned +34.6% over the same windows. Numbers describe the window shown; they are not a forecast.

Gilbert Ray Cisneros, Jr.House · Armed Services · Small BusinessFiled this one in 29dmixed$16K

Committee overlap is a fact, not an accusation. An option leg behind a share buy reads very differently from a plain purchase, so it is called out but never scored as intent.

No disclosed option legs on HALO yet. They plot here the day they file.

A call and a put are shown as filed. We do not infer whether a leg is a hedge or a leveraged bet, because the filing does not say. Read the strike and expiry, not an implied intent.

13F fund positions on HALO light up when fund ingestion lands. Quarter-end marks, up to 45 days lagged, never live holdings.

No convergence: HALO is not showing congress and insider filings together in the last 90 days.

Sources file on different clocks; an overlap like this is rare.